Description
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Elvitegravir
Product ID E4785
Cas No. 697761-98-1
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 697761-98-1 |
|---|---|
| Purity | ≥98% |
| Formula | C23H23ClFNO5 |
| Formula Wt. | 447.88 |
| IUPAC Name | 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid |
| Synonym | GS-9137, JTK-303 |
| Solubility | DMSO 89 mg/mL (198.71 mM) Ethanol 35 mg/mL (78.14 mM) Water Insoluble |
| Appearance | White to off white powder |
Shipping and Storage
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
References
Reviriego C. Elvitegravir for the treatment of HIV infection. Drugs Today (Barc). 2014 Mar;50(3):209-17. PMID: 24696866.
Shimura K, Kodama E, Sakagami Y, et al. Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol. 2008 Jan;82(2):764-74. PMID: 17977962.